Italian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Pagina 1 a partire dal 34 risultati
PCP receptor ligands and the use thereof
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
The invention is in the field of pharmaceutical compositions which are useful for the prevention and/or treatment of neurodegradation and other neuropathological conditions in animals.
BACKGROUND OF THE INVENTION
The amino acid L-glutamate is widely thought to act as a
PCP receptor ligands and the use thereof
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
The invention is in the field of pharmaceutical compositions which are useful for the prevention and/or treatment of neurodegradation and other neuropathological conditions in animals.
BACKGROUND OF THE INVENTION
The amino acid L-glutamate is widely thought to act as a
Crystalline forms of tricyclic compound acid salt or hydrate thereof, and method for making thereof
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The present disclosure relates to novel crystalline acid salts of a tricyclic derivative or a hydrate thereof, and a production method thereof.
BACKGROUND
Drugs administered orally show medicinal effects through absorption, distribution, metabolism or elimination, and the intrinsic
Substituted 5-membered ring compounds and their use
Solo gli utenti registrati possono tradurre articoli
Entra registrati
This application is a U.S. National Stage application of co-pending PCT application PCT/GB2004/002755, filed Jun. 24, 2004, which claims the priority of Great Britain Patent Application No. 0315111.5, filed Jun. 27, 2003. These applications are incorporated herein by reference in their
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
This invention relates to N,N'-disubstituted guanidine analogues, and to compounds and pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods for treating any disease of the nervous system in
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention is in the field of medicinal chemistry. In particular, this invention relates to N,N'-disubstituted guanidine analogues, and to compounds and pharmaceutical composition comprising the same, which possess neuroprotective capability. This invention further relates
Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid
Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid
Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity
Solo gli utenti registrati possono tradurre articoli
Entra registrati
This invention relates to novel branched adamantyl, noradamantyl aryl and aralkylpiperazines having serotonin 5-HT.sub.1A activity. More particularly, the present invention relates to compounds and methods using them to provide neuroprotection and prevent, inhibit or limit processes of
Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-HT1A activity
Solo gli utenti registrati possono tradurre articoli
Entra registrati
This invention relates to novel branched adamantyl, noradamantyl aryl and aralkylpiperazines having serotonin 5-HT.sub.1A activity. More particularly, the present invention relates to compounds and methods using them to provide neuroprotection and prevent, inhibit or limit processes of
Il database di erbe medicinali più completo supportato dalla scienza
- Funziona in 55 lingue
- Cure a base di erbe sostenute dalla scienza
- Riconoscimento delle erbe per immagine
- Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
- Leggi le pubblicazioni scientifiche relative alla tua ricerca
- Cerca le erbe medicinali in base ai loro effetti
- Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti
Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate
